GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: IAMA-6 is a small molecule inhibitor of the basolateral Na-K-Cl symporter NKCC1 (SLC12A2). The chemical structure was disclosed during the 'First Time disclosures' session at the ACS Spring 2025 meeting in San Diego and this was matched to ARN23746/compound 1 in [1]. IAMA-6 is intended as an orally bioavailable agent that targets NKCC1-associated neuronal hyperexcitability as a mechanism to restore neuronal excitability as a treatment for neurological disorders, including autism and epilepsies in paediatric patients.
|
|
References |
1. Borgogno M, Savardi A, Manigrasso J, Turci A, Portioli C, Ottonello G, Bertozzi SM, Armirotti A, Contestabile A, Cancedda L et al.. (2021)
Design, Synthesis, In Vitro and In Vivo Characterization of Selective NKCC1 Inhibitors for the Treatment of Core Symptoms in Down Syndrome. J Med Chem, 64 (14): 10203-10229. [PMID:34137257] |